Updates in the Eighth Edition of the Tumor-Node-Metastasis Staging Classification for Urologic Cancers.

[1]  S. Boorjian,et al.  Independent Validation of the American Joint Committee on Cancer 8th Edition Prostate Cancer Staging Classification , 2017, The Journal of urology.

[2]  B. Delahunt,et al.  Clear cell renal cell carcinoma: validation of World Health Organization/International Society of Urological Pathology grading , 2017, Histopathology.

[3]  D. Sahoo,et al.  Analysis of T1 Bladder Cancer on Biopsy and Transurethral Resection Specimens: Comparison and Ranking of T1 Quantification Approaches to Predict Progression to Muscularis Propria Invasion , 2017, The American journal of surgical pathology.

[4]  Fan Zhou,et al.  Subclassification of pN3 staging systems for penile cancer: Proposal for modification of the current TNM classification. , 2017, Urologic oncology.

[5]  Y. Tsai,et al.  Preliminary evidence of polymorphisms of cell cycle regulatory genes and their roles in urinary tract urothelial cancer susceptibility and prognosis in a Taiwan population. , 2017, Urologic oncology.

[6]  J. Cheville,et al.  UICC drops the ball in the 8th edition TNM staging of urological cancers , 2017, Histopathology.

[7]  D. Berney,et al.  Reporting and Staging of Testicular Germ Cell Tumors: The International Society of Urological Pathology (ISUP) Testicular Cancer Consultation Conference Recommendations. , 2017, The American journal of surgical pathology.

[8]  J. McKenney,et al.  Prostate cancer – major changes in the American Joint Committee on Cancer eighth edition cancer staging manual , 2017, CA: a cancer journal for clinicians.

[9]  M. Amin,et al.  Challenges in Pathologic Staging of Bladder Cancer: Proposals for Fresh Approaches of Assessing Pathologic Stage in Light of Recent Studies and Observations Pertaining to Bladder Histoanatomic Variances. , 2017, Advances in anatomic pathology.

[10]  Mahul B Amin,et al.  Contemporary Gleason Grading of Prostatic Carcinoma: An Update With Discussion on Practical Issues to Implement the 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma , 2017, The American journal of surgical pathology.

[11]  C. Compton,et al.  The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population‐based to a more “personalized” approach to cancer staging , 2017, CA: a cancer journal for clinicians.

[12]  Maximilian Burger,et al.  EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016. , 2017, European urology.

[13]  D. Berney,et al.  The World Health Organization 2016 classification of testicular non‐germ cell tumours: a review and update from the International Society of Urological Pathology Testis Consultation Panel , 2017, Histopathology.

[14]  J. Melamed,et al.  Modification of the pT2 substage classification in prostate adenocarcinoma. , 2016, Human pathology.

[15]  Susan Halabi,et al.  American Joint Committee on Cancer acceptance criteria for inclusion of risk models for individualized prognosis in the practice of precision medicine , 2016, CA: a cancer journal for clinicians.

[16]  J Alfred Witjes,et al.  Accuracy of Magnetic Resonance Imaging for Local Staging of Prostate Cancer: A Diagnostic Meta-analysis. , 2016, European urology.

[17]  L. Egevad,et al.  A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score. , 2016, European urology.

[18]  S. Roman-Roman,et al.  Modification of N staging systems for penile cancer: a more precise prediction of prognosis , 2015, British Journal of Cancer.

[19]  A. Horwich,et al.  Guidelines on Testicular Cancer: 2015 Update. , 2015, European urology.

[20]  P. Karakiewicz,et al.  Development and external validation of a prognostic tool for prediction of cancer‐specific mortality after complete loco‐regional pathological staging for squamous cell carcinoma of the penis , 2015, BJU international.

[21]  S. Daneshmand,et al.  Urothelial carcinoma in bladder diverticula: outcomes after radical cystectomy , 2015, World Journal of Urology.

[22]  B. Delahunt,et al.  The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System , 2015, The American journal of surgical pathology.

[23]  B. Delahunt,et al.  Handling and reporting of orchidectomy specimens with testicular cancer: areas of consensus and variation among 25 experts and 225 European pathologists , 2015, Histopathology.

[24]  F. Zhou,et al.  Modification of N staging systems for penile cancer: a more precise prediction of prognosis , 2015, British Journal of Cancer.

[25]  J. Cheville,et al.  Urothelial carcinoma involving the prostate: the association of revised tumour stage and coexistent bladder cancer with survival after radical cystectomy , 2014, BJU international.

[26]  S. Daneshmand,et al.  Significance of perivesical lymph nodes in radical cystectomy for bladder cancer. , 2014, Urologic oncology.

[27]  J. Carles,et al.  Prognostic factors for relapse in stage I seminoma: a new nomogram derived from three consecutive, risk-adapted studies from the Spanish Germ Cell Cancer Group (SGCCG). , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

[28]  P. Warde,et al.  Evaluation of a prognostic model for risk of relapse in stage I seminoma surveillance , 2014, Cancer medicine.

[29]  J. McKenney,et al.  Rhabdoid Differentiation Is Associated With Aggressive Behavior in Renal Cell Carcinoma: A Clinicopathologic Analysis of 76 Cases With Clinical Follow-up , 2014, The American journal of surgical pathology.

[30]  M. Morris,et al.  Updated prognostic model for predicting overall survival in first-line chemotherapy for patients with metastatic castration-resistant prostate cancer. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[31]  A. Armstrong,et al.  Prognostic model predicting metastatic castration-resistant prostate cancer survival in men treated with second-line chemotherapy. , 2013, Journal of the National Cancer Institute.

[32]  B. Delahunt,et al.  Handling and Staging of Renal Cell Carcinoma: The International Society of Urological Pathology Consensus (ISUP) Conference Recommendations , 2013, The American journal of surgical pathology.

[33]  J. Cheville,et al.  The International Society of Urological Pathology (ISUP) Grading System for Renal Cell Carcinoma and Other Prognostic Parameters , 2013, The American journal of surgical pathology.

[34]  G. Sonpavde,et al.  Nomogram for predicting survival in patients with unresectable and/or metastatic urothelial cancer who are treated with cisplatin‐based chemotherapy , 2013, Cancer.

[35]  Geoffrey E. Wile,et al.  Penile cancer: Clinical Practice Guidelines in Oncology. , 2013, Journal of the National Comprehensive Cancer Network : JNCCN.

[36]  I. Ostrovnaya,et al.  Prognostic model for predicting survival of patients with metastatic urothelial cancer treated with cisplatin-based chemotherapy. , 2013, Journal of the National Cancer Institute.

[37]  K. Trpkov,et al.  Testicular hilum and vascular invasion predict advanced clinical stage in nonseminomatous germ cell tumors , 2013, Modern Pathology.

[38]  T. H. van der Kwast,et al.  A new and highly prognostic system to discern T1 bladder cancer substage. , 2012, European urology.

[39]  M. Amin,et al.  Limited smoothelin expression within the muscularis mucosae: validation in bladder diverticula. , 2011, Human pathology.

[40]  J. Epstein.  Prognostic significance of tumor volume in radical prostatectomy and needle biopsy specimens. , 2011, The Journal of urology.

[41]  X. Yao,et al.  New N staging system of penile cancer provides a better reflection of prognosis. , 2011, The Journal of urology.

[42]  J. Patard,et al.  Tumor grade improves the prognostic ability of American Joint Committee on Cancer stage in patients with penile carcinoma. , 2011, The Journal of urology.

[43]  T. Matsuda,et al.  Outcome of different post-orchiectomy management for stage I seminoma: Japanese multi-institutional study including 425 patients , 2010, International journal of urology : official journal of the Japanese Urological Association.

[44]  Lars Egevad,et al.  International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 2: T2 substaging and prostate cancer volume , 2010, Modern Pathology.

[45]  A. Osunkoya,et al.  Rete testis invasion by malignant germ cell tumor and/or intratubular germ cell neoplasia: what is the significance of this finding? , 2010, Human pathology.

[46]  Yair Lotan,et al.  Characteristics and outcomes of patients with clinical T1 grade 3 urothelial carcinoma treated with radical cystectomy: results from an international cohort. , 2010, European urology.

[47]  S. Herrell,et al.  Pathological stage T2 subgroups to predict biochemical recurrence after prostatectomy. , 2009, The Journal of urology.

[48]  D. Trusty,et al.  Histopathologic features and clinical outcomes in 71 cases of bladder diverticula. , 2009, Archives of pathology & laboratory medicine.

[49]  A. Villers,et al.  Renal cell carcinoma with rhabdoid features: an aggressive neoplasm with overexpression of p53. , 2009, Archives of pathology & laboratory medicine.

[50]  V. Reuter,et al.  Comparison of Morphologic Features and Outcome of Resected Recurrent and Nonrecurrent Squamous Cell Carcinoma of the Penis: A Study of 81 Cases , 2009, The American journal of surgical pathology.

[51]  M. Gallee,et al.  Evaluation of current TNM classification of penile carcinoma. , 2008, The Journal of urology.

[52]  Hao Liu,et al.  Histologic Grade and Perineural Invasion are More Important Than Tumor Thickness as Predictor of Nodal Metastasis in Penile Squamous Cell Carcinoma Invading 5 to 10 mm , 2008, The American journal of surgical pathology.

[53]  D. Grignon,et al.  Renal Cell Carcinoma and the Renal Sinus , 2007, Advances in anatomic pathology.

[54]  A. Haese*,et al.  The 2002 AJCC pT2 substages confer no prognostic information on the rate of biochemical recurrence after radical prostatectomy. , 2006, European urology.

[55]  J. Melamed,et al.  Sarcomatoid Carcinoma of the Penis: A Clinicopathologic Study of 15 Cases , 2005, The American journal of surgical pathology.

[56]  T. H. van der Kwast,et al.  A new system for substaging pT1 papillary bladder cancer: a prognostic evaluation. , 2005, Human pathology.

[57]  S. Ricci,et al.  Long-Term Survival Results of a Randomized Trial Comparing Gemcitabine Plus Cisplatin, With Methotrexate, Vinblastine, Doxorubicin, Plus Cisplatin in Patients With Bladder Cancer , 2005 .

[58]  Liang Cheng,et al.  Does pT2b prostate carcinoma exist? Critical appraisal of the 2002 TNM classification of prostate carcinoma , 2004, Cancer.

[59]  J. Chin,et al.  The prognostic significance of metastatic perivesical lymph nodes identified in radical cystectomy specimens for transitional cell carcinoma of the bladder. , 2003, The Journal of urology.

[60]  G. Dalbagni,et al.  Carcinoma in a bladder diverticulum: presentation and treatment outcome. , 2003, The Journal of urology.

[61]  R. Cohen,et al.  Adult Rhabdoid Renal Cell Carcinoma Divergent Differentiation of Conventional (Clear Cell) Carcinoma , 2002 .

[62]  A. Horwich,et al.  Prognostic Factors for Relapse in Stage I Seminoma Managed by Surveillance: A Pooled Analysis , 2002 .

[63]  L. Seymour,et al.  Long-term survival in phase II trials of gemcitabine plus cisplatin for advanced transitional cell cancer. , 2002, Urologic oncology.

[64]  P. Tamboli,et al.  Tumor stage, vascular invasion and the percentage of poorly differentiated cancer: independent prognosticators for inguinal lymph node metastasis in penile squamous cancer. , 2001, The Journal of urology.

[65]  J. Pfeifer,et al.  Renal cell carcinoma with rhabdoid features. , 2000, The American journal of surgical pathology.

[66]  M. Mazumdar,et al.  Long-term survival in metastatic transitional-cell carcinoma and prognostic factors predicting outcome of therapy. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[67]  S. Groshen,et al.  Transitional cell carcinoma involving the prostate with a proposed staging classification for stromal invasion. , 1996, The Journal of urology.

[68]  A. C. Broders.  SQUAMOUS‐CELL EPITHELIOMA OF THE SKIN A STUDY OF 256 CASES , 1921, Annals of surgery.

[69]  Jonathan I. Epstein,et al.  WHO Classification of of Tumours of the Urinary System and Male Genital Organs , 2016 .

[70]  E. Compérat,et al.  EAU guidelines on penile cancer: 2014 update. , 2015, European urology.

[71]  Hodgkin Lymphoma.  NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines , 2014 .

[72]  D. Hansel,et al.  Validation of new AJCC exclusion criteria for subepithelial prostatic stromal invasion from pT4a bladder urothelial carcinoma. , 2013, The Journal of urology.

[73]  Rodolfo Montironi,et al.  International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 3: extraprostatic extension, lymphovascular invasion and locally advanced disease , 2011, Modern Pathology.

[74]  B. Delahunt,et al.  International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 4: seminal vesicles and lymph nodes , 2011, Modern Pathology.

[75]  Liang Cheng,et al.  International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 5: surgical margins , 2011, Modern Pathology.

[76]  Leslie H. Sobin,et al.  TNM Classification of Malignant Tumours, 7th Edition , 2009 .

[77]  Yair Lotan,et al.  Discrepancy between clinical and pathologic stage: impact on prognosis after radical cystectomy. , 2007, European urology.

[78]  S. Bonsib.  Renal veins and venous extension in clear cell renal cell carcinoma , 2007, Modern Pathology.

[79]  J. Jamart,et al.  Transitional cell carcinoma involving the prostate: a clinicopathological retrospective study of 76 cases. , 2003, The Journal of urology.

[80]  C. Compton,et al.  AJCC Cancer Staging Manual , 2002, Springer New York.

[81]  P. Bassi,et al.  Is stage pT4a (D1) reliable in assessing transitional cell carcinoma involvement of the prostate in patients with a concurrent bladder cancer? A necessary distinction for contiguous or noncontiguous involvement. , 1996, The Journal of urology.